alarm
report
grow
microbi
resist
class
antimicrobi
agent
use
differ
infect
also
exist
class
anticanc
drug
use
differ
tumour
warrant
urgent
search
effect
altern
agent
treatment
broadspectrum
bioactiv
silver
nanoparticl
indic
potenti
solv
mani
microbi
resist
problem
certain
extent
antibacteri
antifung
antivir
antiprotozo
acaricid
larvicid
lousicid
anticanc
activ
silver
nanoparticl
recent
attract
attent
scientist
world
aim
present
review
discuss
broadspectrum
multifunct
activ
silver
nanoparticl
stress
therapeut
potenti
smart
nanomedicin
much
emphasi
dedic
antimicrobi
anticanc
potenti
silver
nanoparticl
show
promis
characterist
treatment
prophylaxi
control
infect
well
diagnosi
treatment
differ
cancer
type
multidrug
resist
grow
problem
treatment
infecti
diseas
extens
use
broadspectrum
antibiot
led
resist
classic
antimicrobi
agent
mani
bacteri
human
pathogen
pose
major
threat
global
health
care
problem
resist
emerg
perfectli
depict
preval
among
invas
staphylococc
isol
methicillin
resist
staphylococcu
aureu
countri
johnson
exclus
prerog
bacteria
fact
noxiou
human
pathogen
actual
almost
depriv
effici
drug
control
resist
commonli
use
antimalari
drug
chloroquin
among
plasmodium
falciparum
also
reach
nearli
resist
fall
et
al
emerg
fluconazoleresist
candida
albican
strain
intrins
resist
speci
includ
candida
glabrata
candida
krusei
progress
reduc
efficaci
popular
antimycot
fluconazol
emerg
resist
viral
strain
particularli
hiv
creat
great
problem
antiretrovir
therapi
johnson
et
al
similar
situat
recent
observ
insect
vector
abl
spread
sever
infect
tick
mosquito
lice
demonstr
resist
avail
antiarthropod
agent
thu
urgent
need
search
new
altern
treatment
control
infecti
diseas
silver
nanoparticl
agnp
consid
potenti
sourc
novel
antimicrobi
agent
offer
sever
advantag
broadspectrum
activ
lower
tendenc
induc
resist
owe
uniqu
chemic
physic
properti
tabl
high
surfac
areatovolum
ratio
agnp
possess
mani
import
biolog
activ
duran
marcato
rai
ingl
particular
nanosilv
found
applic
treatment
wound
rigo
et
al
burn
elliott
waterdisinfect
system
zhang
et
al
develop
nanocontain
materi
bone
implant
marsich
et
al
dental
materi
zhang
et
al
antibacteri
dar
et
al
antivir
fayaz
et
al
antiprotozo
adhikari
et
al
antiarthropod
subarani
et
al
anticancer
agent
jeyaraj
et
al
b
one
main
problem
anticanc
treatment
continu
growth
tumour
cell
resist
broad
rang
anticanc
agent
abraham
et
al
document
activ
agnp
differ
type
cancer
cell
line
includ
multidrug
resist
cell
make
promis
altern
known
anticanc
agent
cond
et
al
although
antibacteri
properti
agnp
rel
wellknown
exploit
mani
practic
applic
activ
type
pathogen
arthropod
vector
infect
differ
type
cancer
cell
evalu
recent
year
still
mani
open
question
requir
attent
research
aim
present
review
discuss
broadspectrum
bioactiv
agnp
includ
effect
differ
type
pathogen
microand
macroorgan
bacteria
virus
fungi
protozoan
arthropod
well
tumour
cell
provid
possibl
explan
mechan
action
develop
strategi
futur
studi
area
antimicrobi
properti
nanosilv
known
mani
centuri
evalu
scientif
basi
start
year
sondi
salopeksondi
shame
et
al
among
first
describ
agnp
activ
escherichia
coli
propos
like
explan
observ
effect
author
reveal
format
pit
bacteri
cell
wall
accumul
agnp
cellular
membran
led
increas
permeabl
eventu
death
bacteri
cell
also
attempt
understand
mechan
action
present
three
main
explan
propos
describ
antibacteri
activ
direct
interact
agnp
bacteri
cell
membran
caus
subsequ
membran
damag
complex
compon
locat
insid
cell
sondi
salopeksondi
interact
thiol
group
product
reactiv
oxygen
speci
ro
banerje
et
al
releas
silver
ion
inhibit
respiratori
enzym
also
gener
ro
pal
et
al
devi
joshi
screen
strain
differ
fungi
mycosynthesi
agnp
also
report
signific
efficaci
aureu
streptococcu
pyogen
salmonella
enterica
enterococcu
faecali
moreov
mycosynthes
nanoparticl
also
show
potent
antibacteri
activ
synergist
effect
erythromycin
methicillin
chloramphenicol
ciprofloxacin
klebsiella
pneumonia
enterobact
aerogen
bawaskar
et
al
antibiot
gentamycin
ampicillin
tetracyclin
streptomycin
e
coli
aureu
pseudomona
aeruginosa
bond
et
al
sizedepend
activ
agnp
report
mani
articl
smaller
np
higher
activ
result
may
explain
rel
increas
contact
surfac
area
liu
et
al
shame
et
al
demonstr
antibacteri
activ
differ
size
agnp
peg
gramposit
aureu
gramneg
salmonella
typhimurium
bacteria
disc
diffus
method
report
signific
inhibit
growth
pathogen
conclud
antibacteri
activ
silver
nanoparticl
peg
modifi
control
size
nanoparticl
activ
agnp
decreas
increas
particl
size
factor
influenc
activ
agnp
concentr
size
shape
uv
radiat
combin
differ
antibiot
taken
account
synthesi
process
clinic
use
agnp
similarli
studi
carri
birla
et
al
ingl
et
al
raheman
et
al
etc
alreadi
prove
antibacteri
potenti
silver
nanoparticl
antifung
activ
agnp
less
studi
compar
antibacteri
activ
clearli
illustr
number
public
pubm
search
studi
devot
antibacteri
activ
agnp
reveal
publish
articl
may
number
antifung
studi
discuss
kim
et
al
studi
activ
chemic
synthes
agnp
strain
six
fungal
speci
viz
candida
albican
c
tropicali
c
glabrata
c
parapsilosi
c
krusei
trichophyton
mentagrophyt
agnp
show
potent
activ
differ
strain
mentagrophyt
candida
sp
gajbhiy
et
al
report
effect
biosynthes
silver
nanoparticl
phoma
glomerata
p
herbarum
fusarium
semitectum
trichoderma
sp
c
albican
also
report
synergist
effect
combin
fluconazol
jo
et
al
studi
activ
silver
ion
nanoparticl
two
plantpathogen
fungi
bipolari
sorokiniana
magnaporth
grisea
antifung
activ
agnp
combin
differ
heterocycl
compound
like
thiazolidin
phthalazin
pyrazolo
tetrazolo
hydrazid
pyridazin
deriv
studi
aspergillu
flavu
c
albican
result
confirm
enhanc
activ
agnp
combin
heterocycl
compound
compar
heterocycl
compound
alon
kandil
et
al
similarli
jaidev
narasimha
report
compar
activ
agnp
staphylococcu
sp
bacillu
sp
e
coli
aspergillu
niger
report
higher
zone
inhibit
cm
case
niger
confirm
maximum
activ
compar
staphylococcu
sp
cm
bacillu
sp
cm
e
coli
cm
nasrollahi
et
al
investig
antifung
activ
chemic
synthes
agnp
c
albican
saccharomyc
cerevisia
result
confirm
potenti
activ
agnp
compar
standard
antifung
agent
viz
amphotericin
b
fluconazol
chang
membran
reaction
yeast
elucid
scan
electron
microscopi
savithramma
et
al
synthes
silver
nanoparticl
use
extract
boswellia
ovalifoliolata
shorea
tumbuggaia
svensonia
hyderobadensi
evalu
antifung
activ
flavu
niger
curvularia
sp
fusarium
sp
rhizopu
sp
result
show
three
nanoparticl
synthes
differ
medicin
plant
signific
activ
test
fungi
among
nanoparticl
synthes
svensonia
hyderobadensi
show
higher
activ
compar
agnp
synthes
use
two
plant
kaur
et
al
studi
potenti
antifung
activ
silver
chitosan
nanoparticl
rhizoctonia
solani
flavu
alternaria
alternata
chickpea
seed
anoth
studi
tile
bholay
report
signific
activ
agnp
c
albican
trichophyton
rubrum
aspergillu
fumigatu
extens
studi
xu
et
al
evalu
agnp
natamycin
strain
fungi
patient
suffer
sever
kerat
includ
isol
fusarium
isol
aspergillu
alternaria
isol
author
report
agnp
demonstr
higher
activ
compar
natamycin
recent
dar
et
al
report
remark
antimicrobi
activ
agnp
synthes
cryphonectria
sp
aureu
e
coli
salmonella
typhi
c
albican
conclud
agnp
use
potenti
antifung
agent
spite
variou
report
antifung
activ
agnp
precis
mechan
effect
report
one
possibl
explan
destruct
membran
integr
fungi
inhibit
normal
bud
process
yeast
similarli
bacteria
disturb
membran
penetr
may
also
lead
intern
nanoparticl
subsequ
intracellular
effect
includ
ro
gener
interact
sh
group
inhibit
protein
synthesi
interact
phosphoruscontain
molecul
dna
agnp
receiv
tremend
attent
antibacteri
activ
antivir
properti
metal
nanoparticl
remain
undevelop
area
galdiero
et
al
nowaday
effect
safe
antivir
therapi
avail
led
signific
improv
life
larg
number
patient
nevertheless
virus
still
repres
one
lead
caus
diseas
death
worldwid
moreov
emerg
reemerg
viral
diseas
major
threat
human
veterinari
health
wit
exampl
occur
approxim
one
year
major
virus
origin
anim
reservoir
consequ
abil
switch
new
host
best
known
exampl
sar
corona
viru
west
nile
viru
monkey
pox
viru
hantaviru
nipah
viru
hendraviru
chikungunya
viru
last
least
threat
pandem
influenza
virus
recent
avian
swine
origin
mani
factor
respons
chang
local
ecosystem
disturb
balanc
pathogen
princip
host
speci
one
major
driver
togeth
increas
urban
chang
human
behaviour
howard
fletcher
therefor
greater
need
develop
new
uniqu
treatment
option
antivir
agent
also
overcom
problem
antivir
resist
agnp
emerg
one
option
manag
viral
diseas
due
potenti
antivir
activ
galdiero
et
al
import
applic
agnp
treatment
viral
diseas
requir
mainten
circul
drug
concentr
long
last
therapeut
regimen
agnp
activ
broad
rang
virus
present
lower
possibl
develop
resist
compar
convent
antivir
ideal
antivir
agent
display
broadspectrum
action
mani
viral
speciesstrain
use
first
aid
compound
unforeseen
viral
epidem
pandem
greatli
need
antivir
agent
arsen
therefor
agnp
receiv
consider
attent
due
particular
intrins
properti
especi
sinc
shown
antivir
efficaci
sever
virus
regardless
specif
famili
nevertheless
differ
nanoparticl
differ
properti
consequ
product
method
size
shape
cap
agent
level
dispers
avail
data
literatur
quit
heterogen
difficult
categor
three
key
aspect
extrapol
studi
conduct
far
antivir
properti
agnp
howev
precis
mechan
agnp
antivir
activ
exact
stage
infect
agnp
exert
antivir
activ
yet
determin
possibl
gener
mechan
fig
antivir
activ
silver
nanoparticl
deriv
avail
literatur
see
refer
throughout
section
sever
studi
analys
behaviour
nake
without
cap
agent
agnp
inhibit
differ
virus
name
hepat
b
viru
hbv
lu
et
al
influenza
viru
mehrbod
et
al
xiang
et
al
human
parainfluenza
viru
type
gaikwad
et
al
herp
simplex
viru
type
type
gaikwad
et
al
sun
et
al
coxsackieviru
salem
et
al
tacarib
viru
tcrv
speshock
et
al
vaccinia
viru
trefri
wooley
monkeypox
viru
mpv
roger
et
al
gener
plot
activ
nake
nanoparticl
virus
difficult
draw
consequ
differ
agnp
product
procedur
differ
size
fact
though
abl
inhibit
coxakieviru
infect
doserespons
effect
salem
et
al
nanoparticl
deriv
ricinu
communi
aqueou
extract
measur
nm
therefor
could
bare
consid
nanoparticl
agnp
produc
fungi
contain
size
size
rang
nm
show
consist
abil
reduc
infect
gaikwad
et
al
product
antivir
agnp
differ
fungi
feasibl
method
fungi
strain
result
product
silver
nanoparticl
consider
toxic
nanoparticl
produc
fusarium
oxysporum
curvularia
sp
chaetomium
indicum
present
low
toxic
level
promis
antivir
activ
lu
et
al
demonstr
larger
nanoparticl
nm
present
high
level
cytotox
cell
culturebas
assay
smaller
nanoparticl
show
minor
toxic
fact
hbv
could
effici
inhibit
nm
nanoparticl
activ
probabl
due
specif
interact
nanoparticl
doublestrand
dna
hbvandor
direct
bind
viral
particl
consequ
prevent
virion
enter
host
cell
studi
antivir
test
cytotox
assay
perform
use
stabli
transfect
hepatoblastoma
cell
line
secret
hbvlike
particl
express
high
level
hbv
dna
supernat
similarli
influenza
viru
effici
inhibit
agnp
averag
size
nm
xiang
et
al
nake
agnp
could
provid
strong
protect
influenza
viru
infect
without
risk
cell
toxic
mehrbod
et
al
xiang
et
al
anoth
studi
focus
tcrv
arenavirida
famili
shown
excel
activ
nm
particl
compar
nm
particl
speshock
et
al
agnp
seem
interact
tcrv
prior
cellular
exposur
result
either
prevent
viral
particl
intern
interf
cellular
receptor
bind
may
favour
intern
agnp
togeth
viru
produc
inhibitori
effect
viral
replic
interf
tcrv
rnadepend
rna
polymeras
overal
pictur
show
tendenc
smaller
size
nanoparticl
incis
reduc
infect
regardless
viral
speci
exert
minor
cytotox
cap
agent
ad
nake
silver
nanoparticl
polyvinylpyrrolidon
citrat
polyethylen
glycol
etc
also
proven
biolog
compat
reduc
infect
howev
may
render
agnp
less
efficaci
fact
polysaccharid
coat
protect
cell
toxic
effect
agnp
also
reduc
activ
tcrv
speshock
et
al
inde
cap
agent
prove
efficaci
mpv
polysaccharideco
agnp
nm
highli
effect
reduc
mpvinduc
plaqu
format
vitro
concentr
rang
roger
et
al
exampl
coat
agnp
offer
sever
studi
antivir
target
human
immunodefici
viru
lara
et
al
lara
et
al
b
sun
et
al
hsv
barampinto
et
al
respiratori
syncyti
viru
rsv
agnp
surfac
coat
poli
pvp
within
rang
nm
prove
efficaci
nanoparticl
inhibit
replic
hiv
dosedepend
manner
elechiguerra
et
al
agnp
abl
inhibit
number
isol
includ
laboratori
strain
clinic
isol
macrophag
tropic
lymphocyt
tropic
strain
resist
strain
suggest
may
broadspectrum
agent
lara
et
al
fact
pvpcoat
silver
nanoparticl
test
topic
vagin
microbicid
endow
virucid
activ
prevent
transmiss
infect
use
vitro
human
cervic
tissuebas
organ
cultur
simul
vivo
condit
lara
et
al
coat
polyurethan
condom
directli
inactiv
infecti
microorgan
fayaz
et
al
studi
prove
sensibl
inactiv
hiv
infect
precis
mechan
action
complet
understood
sever
data
point
direct
interact
agnp
surfac
glycoprotein
interfer
bind
fusion
event
viral
penetr
suscept
cell
furthermor
agnp
abl
inhibit
postentri
stage
life
cycl
fact
antivir
activ
also
maintain
silver
nanoparticl
ad
cell
alreadi
infect
hiv
event
agnp
might
inhibit
postentri
stage
infect
block
function
protein
reduc
revers
transcript
provir
transcript
rate
directli
bind
rna
dna
molecul
also
rsv
fig
mechan
antivir
effect
agnp
differ
stage
viru
replic
viral
surfac
viral
attach
viru
penetr
cell
viral
genom
genom
replic
protein
synthesi
assembl
releas
virion
effici
inhibit
pvpcoat
agnp
probabl
bind
nanoparticl
viral
surfac
possibl
interact
entri
glycoprotein
evenli
distribut
envelop
rsv
virion
differ
cap
agent
name
mercaptoethanesulfon
barampinto
et
al
use
cap
agent
agnp
test
sulfonatecap
agnp
inhibit
infect
block
attach
therebi
entranc
viru
cell
andor
prevent
celltocel
spread
viru
activ
depend
abil
mimic
heparan
sulphat
cellular
primari
receptor
hsv
thu
compet
bind
viru
cell
amplifi
presenc
inner
core
nanosilv
exploit
agnp
antivir
still
infanc
studi
warrant
elucid
mechan
action
may
render
possibl
antivir
develop
agnp
fill
vital
nich
broadspectrum
antivir
agent
oocystproduc
waterborn
intestin
protozoa
giardia
lamblia
especi
cryptosporidium
parvum
resist
tradit
deactiv
procedur
includ
sizeexclus
filter
chlorin
treatment
korich
et
al
pathogen
caus
gastrointestin
infect
throughout
world
furthermor
infect
cryptosporidium
parvum
immunecompromis
individu
lifethreaten
thu
search
new
method
deactiv
pathogen
ultralow
detect
level
great
import
interest
vivo
studi
carri
said
et
al
compar
activ
agnp
chitosan
np
curcumin
np
g
lamblia
experi
rat
maximum
efficaci
achiev
combin
three
type
nanoparticl
agnp
chitosan
np
curcumin
np
compar
use
separ
experi
perform
verifi
effect
agnp
cryptosporidium
parvum
abeb
su
et
al
studi
abeb
direct
assess
disinfect
effect
agnp
cryptosporidium
parvum
develop
effect
system
water
filtrat
howev
final
result
experiment
studi
yet
publish
anoth
import
protozo
infect
leishmaniasi
one
main
neglect
tropic
infect
world
occurr
countri
estim
number
case
viscer
form
million
case
cutan
leishmaniasi
marr
et
al
drug
resist
compromis
present
treatment
option
absenc
effect
vaccin
warrant
search
new
compound
antileishmani
activ
nanotechnolog
impli
two
differ
direct
develop
nanoliposom
formul
contain
convent
antileishmani
drug
instanc
antimoni
amphotericin
b
liposom
duran
et
al
use
nanoparticl
metal
metal
oxid
includ
agnp
ag
tio
nanoparticl
allahverdiyev
et
al
b
c
leishmania
parasit
sensit
ro
murray
howev
multipl
macrophag
block
enzymat
mechan
respons
ro
product
thu
evad
destruct
shio
olivi
one
first
work
antileishmani
activ
agnp
find
signific
differ
reduc
prolifer
leishmania
major
agnp
control
vitro
experi
also
signific
decreas
lesion
size
amastigot
count
vivo
experi
balbc
mice
howev
nanosilvertr
mice
demonstr
signific
decreas
secondari
infect
therefor
conclud
agnp
effect
control
secondari
infect
local
cutan
leishmaniasi
mohebali
et
al
similar
result
regard
lesion
size
splenic
parasit
load
obtain
nilforoushzadeh
et
al
signific
differ
paramet
group
treat
use
chemic
produc
agnp
compar
control
group
without
treatment
howev
rossibergmann
et
al
report
promis
activ
biosynthes
use
f
oxysporum
agnp
leishmania
amazonensi
promastigot
vitro
vivo
also
compar
activ
biolog
chemic
produc
agnp
observ
vitro
experi
biolog
produc
agnp
four
time
potent
chemic
produc
agnp
moreov
vivo
model
even
effect
anoth
recent
studi
vitro
effect
agnp
morpholog
properti
growth
prolifer
metabol
activ
infect
infect
index
percentag
infect
macrophag
multipli
averag
number
amastigot
per
macrophag
leishmania
tropica
evalu
depend
presenc
absenc
uv
irradi
allahverdiyev
et
al
agnp
inhibit
biolog
activ
l
tropica
moreov
effect
enhanc
uv
light
observ
enhanc
effect
uv
light
antileishmani
activ
agnp
attribut
abil
agnp
releas
silver
ion
loos
infecti
abil
leishmania
action
agnp
especi
note
togeth
uv
light
explain
interact
agnp
parasit
surfac
lipophosphoglycan
glycoprotein
molecul
respons
infect
find
import
treatment
leishmaniasi
also
control
spread
applic
agnp
sandfli
vector
carri
infect
promastigot
interestingli
amastigot
appear
sensit
promastigot
even
low
concentr
agnp
nonharm
macrophag
mgl
suppos
result
macrophag
action
exposur
agnp
may
enhanc
product
lytic
enzym
nitric
oxid
also
effect
may
caus
lose
abil
amastigot
affect
neg
ro
product
one
common
protozo
vectorborn
diseas
preval
tropic
subtrop
region
one
million
global
death
per
year
malaria
kamareddin
rapid
growth
resist
plasmodia
antimalari
drug
stimul
continu
search
innov
approach
malari
parasit
also
method
control
spread
mosquito
vector
among
differ
agent
agnp
also
evalu
plasmodia
sever
work
demonstr
promis
result
panneerselvam
et
al
report
activ
agnp
averag
size
approxim
nm
produc
biolog
use
andrographi
paniculata
nee
acanthacea
p
falciparum
ponarulselvam
et
al
report
activ
agnp
averag
size
approxim
nm
produc
use
aqueou
leav
extract
catharanthu
roseu
p
falciparum
ongo
studi
murugan
et
al
demonstr
high
activ
agnp
bioreduc
cassia
occidentali
leaf
broth
chloroquinesensit
chloroquineresist
strain
p
falciparum
malaria
vector
anophel
stephensi
howev
explan
antiplasmodi
effect
publish
studi
recent
year
increas
incid
mani
vectorborn
pathogen
new
geograph
region
kilpatrick
randolph
resist
insecticid
agent
found
among
type
arthropod
vector
tick
found
resist
acaricid
moreov
present
acaricid
substanc
seriou
drawback
contamin
environ
milk
meat
product
happen
insecticid
resist
mosquito
lice
raghavendra
et
al
durand
et
al
owe
interest
scientist
devot
search
antiarthropod
potenti
differ
type
antiparasit
agent
includ
agnp
adhikari
et
al
mani
recent
publish
studi
report
signific
acaricid
larvicid
lousicid
properti
biolog
produc
agnp
prove
repres
innov
approach
control
arthropod
prevent
spread
vectorborn
diseas
spite
fact
mani
publish
studi
prove
antiarthropod
effect
agnp
still
clear
scientif
explan
possibl
larvicid
activ
agnp
hypothes
caus
penetr
nanoparticl
larva
membran
salunkh
et
al
howev
studi
necessari
order
reveal
precis
mechan
antiarthropod
activ
agnp
earli
detect
treatment
cancer
basic
problem
face
cancer
specialist
henc
area
attract
great
attent
one
import
point
effect
anticanc
drug
relat
possibl
reach
target
site
suffici
concentr
effici
activ
without
caus
damag
healthi
tissu
cell
misra
et
al
seigneur
et
al
direct
nanotechnolog
repres
moment
one
new
technolog
possibl
enhanc
diagnosi
treatment
cancer
could
achiev
new
imag
agent
multifunct
target
devic
capabl
bypass
biolog
barrier
deliv
therapeut
agent
directli
biolog
target
involv
cancer
nanobiosensor
predict
diseas
minim
growth
cancer
cell
reduc
cost
treatment
jain
qiao
et
al
metal
nanoparticl
area
appear
import
agent
sinc
use
sever
biomed
applic
highli
sensit
diagnost
assay
biosensor
thermal
radiotherapi
enhanc
qiao
et
al
well
drug
gene
deliveri
rel
low
toxic
bhattacharyya
et
al
cond
et
al
known
agnp
interact
cell
intracellular
macromolecul
like
protein
dna
probabl
ro
show
apoptot
bodi
necrot
cell
death
due
cytotox
biogen
agnp
although
possibl
still
studi
jeyaraj
et
al
b
sever
factor
influenc
toxic
agnp
dose
time
size
particl
cell
cultur
found
toxic
dosedepend
caus
cellular
damag
human
epidermoid
larynx
cell
line
ro
format
jacob
et
al
biolog
synthes
agnp
leaf
suaeda
monoica
cell
exhibit
dosedepend
toxic
concentr
studi
satyavani
et
al
agnp
biogen
synthes
podophyllum
hexandrum
leaf
extract
show
cytotox
apoptot
effect
probabl
caspacecascad
activ
lose
mitochondri
integr
jeyaraj
et
al
piao
et
al
report
hydroxyl
radic
releas
agnp
attack
cellular
compon
includ
dna
lipid
protein
caus
variou
kind
oxid
damag
jeyaraj
et
al
use
biogen
agnp
sesbania
grandiflora
leaf
extract
also
show
cytotox
effect
cell
line
induc
cellular
damag
term
loss
cell
membran
integr
oxid
stress
apoptosi
author
suggest
order
progress
clinic
cancer
treatment
necessari
studi
formul
clinic
trial
establish
nanodrug
treat
cancer
cell
recent
studi
biogen
agnp
vitex
negundo
leaf
extract
show
inhibit
prolifer
human
colon
cancer
cell
line
result
indic
agnp
may
exert
antiprolif
effect
colon
cancer
cell
line
suppress
growth
arrest
reduc
dna
synthesi
induc
apoptosi
prabhu
et
al
inocul
dalton
lymphoma
ascit
cell
mice
produc
tumour
progress
anim
wherea
presenc
agnp
substanti
decreas
cancer
cell
number
tumour
mice
observ
histopatholog
analysi
appar
effect
agnp
increas
mean
surviv
time
life
span
depend
abil
reduc
tumour
cell
viabil
induc
cytotox
sriram
et
al
hematolog
paramet
examin
control
tumour
control
tumourtr
mice
show
effect
agnp
reduc
white
blood
cell
platelet
count
tumourbear
mice
compar
control
data
highlight
nontox
effect
agnp
induc
alter
hematolog
paramet
treat
mice
comparison
control
time
led
effect
control
white
blood
cell
possess
immunolog
constitu
ascit
fluid
corrobor
recent
delima
et
al
cytotox
genotox
biogen
agnp
studi
agnp
demonstr
broadspectrum
activ
differ
type
caus
agent
infecti
diseas
also
arthropod
vector
make
possibl
appli
agnp
treatment
purpos
also
control
infect
fig
recent
studi
direct
address
sever
question
method
synthesi
agnp
optim
properti
enhanc
antimicrobi
effect
minim
potenti
advers
toxic
impact
human
anim
cell
detect
possibl
target
among
microorgan
agnp
potenti
appli
either
alon
combin
convent
antimicrobi
agent
detect
possibl
candid
among
arthropod
vector
transmit
infect
take
account
stage
life
cycl
easili
effect
target
produc
clinic
environment
applic
form
contain
agnp
antimicrobi
coat
microorgan
repel
substanc
arthropod
vector
mani
aspect
global
goal
still
remain
unsolv
studi
nearest
futur
may
help
overcom
present
todat
barrier
studi
combin
use
agnp
antimicrobi
agent
may
solv
problem
toxic
prevent
possibl
risk
resist
develop
investig
also
devot
assess
influenc
biolog
fluid
oxygen
pressur
chemic
biolog
factor
bioactiv
biocompat
agnp
mechan
antimicrobi
antiarthropod
effect
deepli
evalu
understand
molecular
event
action
agnp
may
open
new
perspect
applic
new
possibl
creat
benefici
combin
biolog
activ
agent
broadspectrum
bioactiv
agnp
make
promis
agent
fight
infect
also
tackl
seriou
problem
tumour
particularli
multidrugresist
cancer
cell
agnp
use
diagnost
treatment
differ
cancer
mani
anticanc
research
progress
vitro
assay
vivo
studi
therefor
open
area
mani
new
studi
cancer
treatment
agnp
